AgingResearch.News
Cureus

GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review

By Agnieszka Buczkowska, Michal Glinski, Julia Danieluk, Show 6 more authorsJulia Sochowska
Figure 1. Mechanisms of hypothalamic receptor dysregulation and AMPK activation underlying antipsychotic-induced weight gain.
Open the figure at full size
Figure 1. Mechanisms of hypothalamic receptor dysregulation and AMPK activation underlying antipsychotic-induced weight gain.Mechanisms of hypothalamic receptor dysregulation and AMPK activation underlying antipsychotic-induced weight gain.Buczkowska et al.
ReviewInterventions
Paper

The paper

Agnieszka Buczkowska, Michal Glinski, Julia Danieluk, Show 6 more authorsJulia Sochowska

Poznan University of Medical Sciences

Cureus, 12 Aug 2026

doi.org/10.7759/cureus.114435PubMed 42730175

More on GLP-1 and incretin signalling